Diabetic retinopathy (DR) screening commonly relies on fixed follow-up intervals, although progression risk differs across patients. We developed a preliminary image–clinical framework to support personalized follow-up recommendations from retinal fundus images and systemic risk factors. Public DR datasets were harmonized into a binary task distinguishing absence of DR from DR of any grade. An ImageNet-pretrained ResNet50 and a foundation model-based feature extraction pipeline were compared. The selected image model was integrated with literature-derived severe retinopathy progression curves and clinical risk modifiers to estimate personalized cumulative risk and assign follow-up intervals using a predefined acceptable risk threshold. The ResNet50-based model was selected for subsequent analyses. In the target cohort, the integrated model assigned 90.0% of patients to follow-up within 12 months. Clinical adjustment substantially modified image-only recommendations, generally shifting patients toward shorter intervals. These preliminary findings support the feasibility of combining image-derived estimates of baseline DR status with clinical modifiers to inform personalized screening intervals. Larger longitudinal studies are needed to validate calibration, clinical utility, and safety before real-world implementation.
Toward Personalized Diabetic Retinopathy Screening: Deep Learning Fundus Image Analysis and Clinical Risk Factors
Flavio Ragni;Paolo Bresolin;Stefano Bovo;Giulia Malfatti;Sandro Inchiostro;Monica Moroni;Giuseppe Jurman
2026-01-01
Abstract
Diabetic retinopathy (DR) screening commonly relies on fixed follow-up intervals, although progression risk differs across patients. We developed a preliminary image–clinical framework to support personalized follow-up recommendations from retinal fundus images and systemic risk factors. Public DR datasets were harmonized into a binary task distinguishing absence of DR from DR of any grade. An ImageNet-pretrained ResNet50 and a foundation model-based feature extraction pipeline were compared. The selected image model was integrated with literature-derived severe retinopathy progression curves and clinical risk modifiers to estimate personalized cumulative risk and assign follow-up intervals using a predefined acceptable risk threshold. The ResNet50-based model was selected for subsequent analyses. In the target cohort, the integrated model assigned 90.0% of patients to follow-up within 12 months. Clinical adjustment substantially modified image-only recommendations, generally shifting patients toward shorter intervals. These preliminary findings support the feasibility of combining image-derived estimates of baseline DR status with clinical modifiers to inform personalized screening intervals. Larger longitudinal studies are needed to validate calibration, clinical utility, and safety before real-world implementation.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
